Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey


Creative Commons License

FERHANOĞLU A. B., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., GÜLBAŞ z., TÜRKER F. A., ...Daha Fazla

Hematological Oncology, cilt.35, ss.321-323, 2017 (SCI-Expanded, Scopus) identifier identifier identifier